Here we present baseline characteristics, prognostic biomarker testing, and treatment patterns for the fully enrolled pt population. This prospective real-world registry is uniquely positioned to examine the impact of the dynamic treatment landscape, treatment practices, and outcomes in routine clinical setting. The informCLL TM registry is the largest US-based prospective, observational registry of pts who received treatment for CLL/SLL in the post-novel agent era.
Background: Treatment options, together with guidelines, for pts with CLL have evolved and expanded with the introduction of novel agents.
0 kommentar(er)
